Genetic analyses further support sex-specific patterns, with women more frequently exhibiting mutations in genes, such as BRAF and TGF-β, which are associated with increased tumor aggressiveness, whereas men more commonly display N-RAS mutations, potentially contributing to more rapid disease progression [39]. This evidence concerns the gene BRAF and neoplasm.